REFERENCES

1. Whaley-Connell AT, Sowers JR, Stevens LA, et al. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008; 51:S13–S20. 
2. Yamamoto S, Kon V. Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens. 2009; 18:181–8. 
3. Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J. 2007; 28:478–83. 
4. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000; 356:147–52.
5. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108:2154–69. 
6. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006; 17:2275–84. 
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296–1305. 
8. Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med. 2006; 260:231–7.
9. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996; 49:1428–34. 
10. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32:S112–S119. 
11. Van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. 2009; 6:580–9. 
12. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the “only-50%” myth. Arch Intern Med. 2001; 161:2657–60. 
13. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62:1524–38. 
14. K Amin, et al. Pattern of Dyslipidemia in patients with CRF. Professional Med J Mar 2006; 13(1): 79-84.
15. G Brosnahan, and M Fraer. Chronic Kidney Disease: Whom to Screen and How to Treat, Part 1: Definition, Epidemiology, and Laboratory Testing. Southern Medical Journal, February 2010, Vol. 103, No. 2.
16. RR Ravichandran, et al. Hyperlipidemia in patients with chronic renal failure. Journal of Post Graduate Medicine, 1983; 29(4): 212- 217.
17. A. S. Fauci. Editor.Harrison’s principles of Internal Medicine. USA: The McGraw Hill’s, 17th edition, chapter 275.
18. M. D. Cressman. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation August1992; 86(2).
19. De Gómez Dumm NT,  Giammona AM,  Touceda LA,  Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina (B Aires). 2001; 61(2):142-6.